[Federal Register Volume 61, Number 42 (Friday, March 1, 1996)]
[Notices]
[Page 8068]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-4746]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute Notice of Meetings
Pursuant to Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings of the National Cancer Institute Board of Scientific Advisors
and the Board of Scientific Counselors, National Cancer Institutes on
March 21, 1996 at the National Institutes of Health, 9000 Rockville
Pike Building 31, C Wing, 6th Floor, Conference Rooms 10, 9 and 8,
Bethesda, MD 20892.
A joint session of the two committees will be open to the public in
Conference Room 10 from 8:30 am to 12:30 pm for orientation of members.
These meetings will be closed to the public as indicated below in
accordance with the provisions set forth in sections 552b(c)(4) and
552b(c)(6), Title 5, U.S.C. for discussion of confidential issues
relating to the review and evaluation of individual programs and
projects. These discussions will reveal confidential trade secrets or
commercial property such as patentable material, and personal
information including consideration of personnel qualifications and
performance, the competence of individual investigators and similar
matters, the disclosure of which would constitute a clearly unwarranted
invasion of personal privacy.
Committee Name: National Cancer Institute Board of Scientific
Advisors.
Closed: March 21, 1996, 12:30 to 5:00 pm.
Agenda: To discuss confidential issues relating to the review
and evaluation of individual extramural programs and projects.
Committee Name: Board of Scientific Counselors, National Cancer
Institute.
Closed: March 21, 1996, 12:30 to 5:00 pm.
Agenda: To discuss administrative confidential site visit
reports pertaining to laboratories in the Divisions of Basic and
Clinical Sciences.
Information pertaining to the meetings may be obtained from Dr.
Paulette Gray, Executive Secretary, National Cancer Institute Board
of Scientific Advisors, National Cancer Institute, 6130 Executive
Blvd., EPN, Rm 600, Bethesda, MD 20892, (301-496-4218). Individuals
who plan to attend the open session and need special assistance such
as sign language interpretation or other reasonable accommodations
should contact Dr. Paulette Gray in advance of the meeting.
Dated: February 23, 1996.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 96-4746 Filed 2-29-96; 8:45 am]
BILLING CODE 4140-01-M
